Company / Profit Margin
InMed Pharmaceuticals Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-166.9%
FY2025
5-year range
-1707.3% / -166.9%
FY2022-FY2025
Trend
+13.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -1707.3% to -166.9% over the past 2 years.
Based on SEC 10-K filings.
-166.9% in FY2025 with a 3-year CAGR of +769.6%.
Improved from -1707.3% to -166.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +769.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 13.1% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -166.9% | +13.1% |
| FY2024 | -192.2% | +88.7% |
| FY2023 | -1707.3% | -82.3% |
| FY2022 | -936.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026